TLR4 and necrotizing enterocolitis: New pre-clinical evidence has demonstrated that breast milk is capable of attenuating the TLR4-mediated pro-inflammatory response integral to NEC pathogenesis by activating the receptor for epidermal growth factor (EGFR), revealing the interplay between the EGF pathway and the hallmark TLR4 signaling of NEC (95).